New approach needed to study autoimmune diseases ANI | Updated: Jan 10, 2021 21:39 IST
Washington [US], January 10 (ANI): A research team has recently determined that the Immune only focus of the current research must be updated to better understand autoimmune diseases such as type 1 diabetes and multiple sclerosis.
A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center s Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues. This study, Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis, is featured in the Jan. 6, 2021, edition of Science Advances.
New approach can help identify novel treatments for autoimmune diseases
A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center s Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune diseases requires studying together the immune system and target tissues.
This study, Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis, is featured in the Jan. 6, 2021, edition of
Science Advances.
We must move away from the present immune-centric-only view of autoimmune diseases. Indeed, trying to understand these diseases focusing on the immune system only, and forgetting the target tissues, may be similar to attempting to fly a plane with only one wing.
E-Mail
IMAGE: Decio Eizirik, MD, PhD, Scientific Director of the Indiana Biosciences Research Institute Diabetes Center. view more
Credit: Indiana Biosciences Research Institute
Indianapolis, Ind. - A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center s Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues. This study, Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis and rheumatoid arthritis, is featured in the Jan. 6, 2021, edition of
Science Advances. We must move away from the present immune-centric-only view of autoimmune diseases, explains Eizirik. Indeed, trying to understand these diseases focusing on the immune system only, and forgetting the target tissues, may be similar to attempting to fly a plane with only one wing.